Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Phrontline Biopharma

Clinical trials sponsored by Phrontline Biopharma, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New cancer drug TJ101 enters first human trials for advanced tumors Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Can a Dual-Payload 'Smart Bomb' outsmart advanced ovarian cancer?

Disease control Not yet recruiting

This early-stage trial is testing an investigational drug called TJ102 in people with advanced or metastatic ovarian cancer and other solid tumors that have stopped responding to standard treatments. TJ102 is a type of targeted therapy called an antibody-drug conjugate, designed …

Phase 1/2 • Sponsor: Phrontline Biopharma • Aim: Disease control

Last updated Aug 23, 2026 00:00 UTC